Saturday 17 October 2026
Export NA’s income statement to Excel — free account
Nano Labs Ltd. Sponsored ADR
Nano Labs Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.8 million, down 32.0% from fiscal 2024. Insiders bought in the last twelve months.
1.92
0.06
+3.23%
Follow NA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 1 | 5 | — | — |
Altman Z-Score |
0.11 | (0.63) | (3.21) | 3.08 | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
1.48 | (1.75) | (11.45) | 1.34 | (2.43) | (16.10) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (6.24) | — | 25.43 | — | — |
P/B ratio |
0.08 | 0.77 | 0.00 | 1.39 | 0.00 | 0.00 |
Price to Tangible BV |
0.09 | 0.96 | 0.00 | 1.97 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.58) | (0.83) | (1.19) | 0.00 | 0.00 | 0.00 |
EV/FCF |
(0.50) | (0.50) | (0.75) | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.28 | 0.16 | 0.21 | 0.61 | 0.32 | 0.35 |
Current Ratio |
2.09 | 1.75 | 0.52 | 1.57 | 0.96 | 0.54 |
Net Debt/EBITDA |
(1.62) | (1.65) | (0.38) | (2.35) | 1.49 | 0.86 |
Debt/Assets |
16.95% | 28.58% | 41.01% | 4.62% | 0.81% | 9.33% |
Debt/Equity |
0.26 | 0.76 | (8.84) | 0.10 | (0.30) | (0.12) |
Asset Turnover |
0.03 | 0.08 | 0.22 | 1.44 | 0.08 | 0.00 |
Operating CF/Net income |
(0.80) | 1.23 | 0.53 | (8.84) | (0.41) | 0.08 |
Capex/Depreciation |
0.15 | (3.13) | (10.37) | (7.08) | (1.57) | 0.00 |
Interest Coverage |
(6.10) | (71.04) | (283.45) | 9.97 | (350.52) | (3,450.58) |
| 27.97% | (104.61%) | (335.00%) | 45.27% | 486.20% | 0.00% | |
| 15.74% | (23.30%) | (69.86%) | 4.57% | (36.08%) | 0.00% | |
ROIC |
(7.49%) | (16.37%) | (206.77%) | 13.83% | 0.00% | 0.00% |
Return on Tangible Assets |
33.24% | (31.92%) | (480.90%) | 24.61% | 551.97% | 73.90% |
Average Days of Receivables |
279.34 | 5.15 | 8.10 | 8.83 | 306.23 | 533.58 |
Research and Development Expense of Revenue |
29.84% | 123.52% | 113.11% | 13.41% | 368.79% | 1,621.23% |
Selling, General and Administrative Expense of Revenue |
219.67% | 147.72% | 87.74% | 7.90% | 74.14% | 154.98% |
Intangible Assets out of Total Assets |
0.04 | 0.08 | 0.14 | 0.13 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.27% | 0.99% | 0.92% | 0.95% | 0.05% | 0.00% |
Graham Net Nets |
0.85 | (0.09) | (0.70) | 0.38 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
(704.59%) | (361.83%) | (170.68%) | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.19 | 0.70 | 1.88 | 53.03 | 2.75 | 0.01 |
Operating CF per Share |
(0.78) | (2.41) | (3.20) | (14.83) | 5.01 | (0.02) |
Capex per Share |
0.01 | (0.63) | (2.53) | (3.60) | (0.61) | 0.00 |
Free Cash Flow per Share |
(0.76) | (3.04) | (5.73) | (18.43) | 4.40 | (0.02) |
Cash per Share |
0.26 | 0.57 | 1.16 | 4.74 | 18.55 | 0.19 |
Shareholders Equity per Share |
5.31 | 4.02 | (0.39) | 8.87 | (1.72) | (0.26) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.31 | 4.02 | (0.39) | 8.87 | (1.72) | (0.26) |
Free Cash Flow |
(15.15) | (24.44) | (33.74) | (49.07) | 9.89 | (0.44) |
Working Capital |
31.99 | 21.87 | (16.53) | 15.08 | (6.11) | (7.76) |
Capital Expenditures |
0.26 | (5.06) | (14.89) | (9.59) | (1.36) | (0.14) |
Net Current Asset Value |
7.43 | (2.28) | (34.04) | 12.32 | (6.44) | (7.80) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
(0.07) | 0.90 | 1.35 | 0.07 | 0.22 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
0.07 | 0.06 | 0.06 | 0.44 | 0.76 | 0.25 |
Cash ROIC |
(11.01%) | (39.77%) | (135.78%) | (126.94%) | 25.38% | 38.52% |
Accounts Receivable Turnover |
2.54 | 34.73 | 6.04 | 32.81 | 2.19 | 0.00 |
Accounts Payable Turnover |
3.60 | 1.65 | 11.21 | 81.88 | 10.47 | 0.00 |
Inventory Turnover |
3.11 | 1.35 | 3.11 | 4.48 | 0.38 | 0.00 |
Average Days of Payables |
106.14 | 227.87 | 33.88 | 7.41 | 23.79 | 1,702.67 |
Days of Inventory on Hand |
74.83 | 375.99 | 25.85 | 49.54 | 1,793.28 | 4,082.61 |
Average Receivables |
1.51 | 0.16 | 1.83 | 4.30 | 2.82 | — |
Average Payables |
2.64 | 2.45 | 2.29 | 1.32 | 0.65 | — |
Average Inventory |
3.05 | 2.99 | 8.25 | 24.11 | 17.80 | — |
Average Assets |
122.48 | 67.57 | 51.09 | 97.72 | 76.05 | — |
Average Common Equity |
68.90 | 15.05 | 10.66 | 9.87 | (5.64) | — |
Columns are period end dates